LEADER 01560nam  2200409   450 
001 9910717232103321
005 20221029105153.0
035   $a(CKB)4100000009163726
035   $a(NjHacI)994100000009163726
035   $a(OCoLC)1099616826
035   $a(EXLCZ)994100000009163726
100   $a20221029d2018      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPharmacotherapy for stimulant use disorders $ea systematic review /$fChan, Brian
210  1$aWashington, D. C. :$cDepartment of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service,$d2018.
215   $a1 online resource (viii, 146 pages)
225 1 $aEvidence-based synthesis program
300   $a"August 2018."
320   $aIncludes bibliographical references.
517   $aPharmacotherapy for stimulant use disorders 
606   $aAmphetamine abuse
615  0$aAmphetamine abuse.
676   $a362.299
700   $aChan$b Brian$01353408
712 02$aPortland VA Medical Center.$bEvidence-based Synthesis Program Center.
712 02$aQuality Enhancement Research Initiative (U.S.)
712 02$aUnited States.$bDepartment of Veterans Affairs.$bHealth Services Research and Development Service,
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910717232103321
996   $aPharmacotherapy for stimulant use disorders$93253925
997   $aUNINA